$0.51
▲ +2.4% Today
as of Oct 22, 16:48 ET
Last 30 days
Recent Press Releases & News
Ensysce Biosciences Expands Global Investor and Strategic Outreach at Family Office Summit, Dubai
Ensysce Biosciences Phase 2 Protocol for CY200 - A Neuroplastigen for the Treatment of CRPS - Submitted to the UK MHRA
Ensysce Biosciences Advances CRPS Program at Painweek 2026, Contributes to FDA Hearing on Psychedelic Drug Regulation
ENSC earnings at a glance
Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±3.3% on average; after the most recent report on May 15, 2026 it moved +1.1%. ENSC beat the consensus EPS estimate in 3 of its last 4 reported quarters. The share price of $0.51 sits near its 52-week low.
Overview
52-week range
$0.23
$2.25
14% of range
Avg surprise (last 4)
+13.4%
Avg reaction (last 2)
-2.2%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.20 | — | — | — | — | financials |
| Fri May 15, 2026 | Mar/2026 | $-0.52 | $-0.73 | +28.8% | +62.6% | +1.1% | earnings |
| Fri Nov 14, 2025 | Sep/2025 | $-1.29 | $-0.85 | -51.8% | — | — | earnings |
| Wed Aug 13, 2025 | Jun/2025 | $-0.79 | $-1.02 | +22.6% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-1.39 | $-3.02 | +54.0% | — | -5.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $1.00 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-3.35 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-8.21 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.87 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.98 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-2.08 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $960,999 | — | $493,104 | $1M | $1M | — | $3M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-3M | $-4M | — | $-4M | $-2M | $-2M | — | $644,746 |
| Net income | $-3M | $-4M | — | $-4M | $-2M | $-2M | — | $661,769 |
| EPS (diluted) | $-0.20 | $-0.52 | — | $-1.29 | $-0.79 | $-1.39 | — | $1.00 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $676,704 | $745,482 | $4M | $2M | $2M | $3M | $4M | $4M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $3M | $2M | $7M | $3M | $5M | $4M | $5M | $9M |
| Total assets | $3M | $2M | $7M | $3M | $6M | $5M | $6M | $9M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $4M | $3M | $5M | $2M | $3M | $2M | $2M | $3M |
| Total equity | $-781,697 | $-669,012 | $3M | $1M | $3M | $3M | $4M | $7M |
Implied volatility — last 90 days
No IV snapshots yet for ENSC.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
ENSC earnings FAQ
How does ENSC stock usually react to earnings?
Across the last 2 reports the average next-day move was ±3.3%, up 1 times and down 1 times.